611 related articles for article (PubMed ID: 12648063)
1. Cytogenetics of multiple myeloma: interpretation of fluorescence in situ hybridization results.
Harrison CJ; Mazzullo H; Cheung KL; Gerrard G; Jalali GR; Mehta A; Osier DG; Orchard KH
Br J Haematol; 2003 Mar; 120(6):944-52. PubMed ID: 12648063
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
3. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
4. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis.
Chang H; Li D; Zhuang L; Nie E; Bouman D; Stewart AK; Chun K
Leuk Lymphoma; 2004 May; 45(5):965-9. PubMed ID: 15291356
[TBL] [Abstract][Full Text] [Related]
5. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
6. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
7. High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization.
Avet-Loiseau H; Brigaudeau C; Morineau N; Talmant P; Laï JL; Daviet A; Li JY; Praloran V; Rapp MJ; Harousseau JL; Facon T; Bataille R
Genes Chromosomes Cancer; 1999 Jan; 24(1):9-15. PubMed ID: 9892103
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic manifestations of multiple myeloma heterogeneity.
Pantou D; Rizou H; Tsarouha H; Pouli A; Papanastasiou K; Stamatellou M; Trangas T; Pandis N; Bardi G
Genes Chromosomes Cancer; 2005 Jan; 42(1):44-57. PubMed ID: 15495197
[TBL] [Abstract][Full Text] [Related]
9. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
[TBL] [Abstract][Full Text] [Related]
10. Both chromosome 13 abnormalities by metaphase cytogenetics and deletion of 13q by interphase FISH only are prognostically relevant in multiple myeloma.
Kaufmann H; Krömer E; Nösslinger T; Weltermann A; Ackermann J; Reisner R; Bernhart M; Drach J
Eur J Haematol; 2003 Sep; 71(3):179-83. PubMed ID: 12930318
[TBL] [Abstract][Full Text] [Related]
11. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
[TBL] [Abstract][Full Text] [Related]
12. The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma.
Fonseca R; Debes-Marun CS; Picken EB; Dewald GW; Bryant SC; Winkler JM; Blood E; Oken MM; Santana-Dávila R; González-Paz N; Kyle RA; Gertz MA; Dispenzieri A; Lacy MQ; Greipp PR
Blood; 2003 Oct; 102(7):2562-7. PubMed ID: 12805059
[TBL] [Abstract][Full Text] [Related]
13. 14q32 translocations and 13q14 deletions are common cytogenetic abnormalities in POEMS syndrome.
Kang WY; Shen KN; Duan MH; Zhang W; Cao XX; Zhou DB; Li J
Eur J Haematol; 2013 Dec; 91(6):490-6. PubMed ID: 23957213
[TBL] [Abstract][Full Text] [Related]
14. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by double-color fluorescent in situ hybridization.
Finelli P; Fabris S; Zagano S; Baldini L; Intini D; Nobili L; Lombardi L; Maiolo AT; Neri A
Blood; 1999 Jul; 94(2):724-32. PubMed ID: 10397739
[TBL] [Abstract][Full Text] [Related]
15. Tumor-specific rearrangements of the immunoglobulin heavy-chain gene in B-cell non-Hodgkin's lymphoma detected by in situ hybridization.
Ueda Y; Matsuda F; Misawa S; Taniwaki M
Blood; 1996 Jan; 87(1):292-8. PubMed ID: 8547654
[TBL] [Abstract][Full Text] [Related]
16. Various patterns of IgH deletion identified by FISH using combined IgH and IgH/CCND1 probes in multiple myeloma and chronic lymphocytic leukemia.
Hwang Y; Lee JY; Mun YC; Seong CM; Chung WS; Huh J
Int J Lab Hematol; 2011 Jun; 33(3):299-304. PubMed ID: 21272268
[TBL] [Abstract][Full Text] [Related]
17. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
18. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of chromosomal aberrations with prognostic markers in multiple myeloma patients--a single institution study].
Lee JW; Lee JK; Hong YJ; Hong SI; Chang YH
Korean J Lab Med; 2008 Dec; 28(6):413-8. PubMed ID: 19127104
[TBL] [Abstract][Full Text] [Related]
20. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
